ArticleMedical science monitor : international medical journal of experimental and clinical research2016

Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37.

Shi-xiong Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.